Jennifer R Brown

74PUBLICATIONS
312CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Tumour immunologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (74)

|Sep 23, 2026
Aberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL.

|Sep 11, 2026
Association between patient-reported symptoms and clinical outcomes in R/R CLL.

|Jul 30, 2026
Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States.

|Jun 23, 2026
Safe Accelerated Venetoclax Escalation: a phase 1b study of obinutuzumab plus venetoclax with daily ramp-up in CLL.

|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

|May 14, 2026
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic Leukemia.

Pageof 13

Frequent Collaborators

11 joint publications

Svitlana Tyekucheva

10 joint publications

Constantine Tam

10 joint publications

Paolo Ghia

9 joint publications

Matthew S Davids